The Beckley Foundation, a charitable trust that promotes the scientific investigation of consciousness, wrote in its Oct. 6, 2010 page "Cannabidiol" on

“Cannabidiol (CBD), a constituent of herbal cannabis, has attracted much interest recently as a promising medicine. After being discovered in the early 1970s it was quickly established that CBD has anti-convulsant and anxiolytic properties in animal models and in humans… Work in the 1980s and early 1990s suggested CBD had anti-psychotic properties and could be an effective treatment for schizophrenia…

In the last decade or so many other properties of CBD have been characterised… CBD has potent anti-inflammatory properties and is a neuroprotectant… CBD appears to protect, not just neurons, but heart muscle from injury. Several groups in the US and UK are pursuing this line which has massive implications for clinical practice. Perhaps even more dramatic is recent work from Mechoulam’s lab which suggests that CBD can restore normal pancreatic functioning in models of type 1 diabetes. The list of putative indications for CBD include…


  1. anxiety
  2. temporal lobe epilepsy
  3. schizophrenia


  1. Rheumatoid arthritis
  2. Type 1 diabetes


  1. Stroke
  2. Head injury


  1. Acute myocardial infarction


  1. Glioma

CBD exhibits an impressive plethora of therapeutic uses, including anticonvulsive, sedative, hypnotic, antipsychotic, anti-inflammatory and neuroprotective properties. CBD is well tolerated in humans, with a profile of very low toxicity, and is devoid of psychoactive and cognitive effects.”

Oct. 6, 2010